Intellectual Property Law

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Jan
10
2024
4.5 Year Prison Sentence and 5.5 Million RMB Fine in China Disney Criminal Trademark Case Schwegman, Lundberg & Woessner, P.A.
Jan
9
2024
Industry Reactions to In re Cellect Decision Womble Bond Dickinson (US) LLP
Jan
8
2024
Nota Bene Episode 168: How Patent Disputes Affect the Semiconductor Industry [PODCAST] Sheppard, Mullin, Richter & Hampton LLP
Jan
8
2024
The Battle of the Bulls: NBA Fail to Invalidate Pizza Texas Bulls Trade Mark Similar to the Chicago Bulls Logo in the United Kingdom K&L Gates
Jan
5
2024
Translation of China’s Amended Implementing Regulations of the Patent Law Schwegman, Lundberg & Woessner, P.A.
Jan
4
2024
2023 New York State Legislature Concludes with Flurry of Activity Pertinent to New York Employers Jackson Lewis P.C.
Jan
4
2024
Three Point Shot - Winter 2024 Proskauer Rose LLP
Jan
4
2024
Year in Review: The Most Popular IP Posts of 2023 Mintz
Jan
4
2024
Espresso Yourself: When Prosecution History as a Whole Doesn’t Demonstrate Clear, Unmistakable Disclaimer McDermott Will & Emery
Jan
4
2024
Same Applicant, Similar Claims Support Obviousness-Type Double Patenting Rejection McDermott Will & Emery
Jan
3
2024
Federal Circuit Clarifies Reach of “Artificial” Act of Patent Infringement Proskauer Rose LLP
Jan
3
2024
Startup Advisors: What is SAFE? [VIDEO] Foley & Lardner LLP
Jan
3
2024
Startup Advisors: How to Identify Potential Investors [VIDEO] Foley & Lardner LLP
Jan
3
2024
Shaping the Future of Higher Education: R2D2 or HAL 9000 ArentFox Schiff LLP
Jan
3
2024
UK Supreme Court rules on AI and Patent Applications Squire Patton Boggs (US) LLP
Jan
2
2024
The Intertwining Nature of Motivation to Combine and Reasonable Expectation of Success Sheppard, Mullin, Richter & Hampton LLP
Dec
27
2023
China’s National Intellectual Property Administration Releases Third Batch of Guiding Cases for Administrative Protection of IP Schwegman, Lundberg & Woessner, P.A.
Dec
26
2023
China’s National Intellectual Property Administration Releases Amended Patent Examination Guidelines – Introduces Inventiveness Examination of Utility Models Schwegman, Lundberg & Woessner, P.A.
Dec
23
2023
China’s Supreme People’s Court Releases the 39th Batch of Guiding Cases Covering Intellectual Property Law Schwegman, Lundberg & Woessner, P.A.
Dec
23
2023
China’s National Intellectual Property Administration to Allow Third-Party Challenges to Pharmaceutical Patent Term Extensions Schwegman, Lundberg & Woessner, P.A.
Dec
22
2023
China Updates Regulations Against Applying for Abnormal Patent Applications Schwegman, Lundberg & Woessner, P.A.
Dec
22
2023
Hey! That’s My Move! Ninth Circuit Remands Choreography Copyright Fortnite Case ArentFox Schiff LLP
Dec
21
2023
China’s State Council Releases Amended Implementing Regulations of the Patent Law Schwegman, Lundberg & Woessner, P.A.
Dec
21
2023
Pharmaceutical Companies Have Rights if the Federal Government Seized their Patents Sheppard, Mullin, Richter & Hampton LLP
Dec
21
2023
Inherent Limitations in Prior Patents can Lead to Obviousness-Type Double-Patenting Mintz
Dec
21
2023
Federal Circuit Affirms PTAB’s Ruling of Obviousness for the Colorization of Fabrics Sheppard, Mullin, Richter & Hampton LLP
Dec
21
2023
“Comparison Prior Art” Must Be Tied to the Same Article of Manufacture as That Claimed Sheppard, Mullin, Richter & Hampton LLP
Dec
21
2023
Anticipation and Obviousness in Patent Law: An Analysis of Recent IPR Decisions Sheppard, Mullin, Richter & Hampton LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins